Enhanced Vancomycin Hemodialysis model now available in DoseMeRx!Learn more →

Whitepapers

All topics

Busulfan

Cyclosporine

Tobramycin

Vancomycin

DoseMe Expands Global Footprint as Premier Hospitals and Cancer Centers across Australia Continue to Adopt Bayesian Dosing

Webinar registration | Improving Critical Care | 04.23.24

DoseMe Bioinformatician and Chief Science and Strategy Officer Co-Author Abstract Big Data Bayesian Truths to Be Covered in Oral Presentation at the 24th ECCMID Annual Meeting

Advanced Infliximab Model Now Available from DoseMe

DoseMe Partners with Albertina icome Praha as Demand for Precision Dosing in Czech and Slovakia Continues to Increase

Vancomycin dosing

DoseMe Expands Vancomycin Hemodialysis Model

DoseMe Expands Its Reseller Agreement with Primum Pharma into the MENA Market

DoseMe Fuels Global Expansion with Appointment of Siegfried Braeuer to Director International Sales

DoseMe Announces 2023 Highlights; Precision Dosing Fast-Tracking to Top Trend in 2024

DoseMe Amplifies Presence in Turkey via Distribution and Reseller Agreement with Primum Pharma

UTMB Taps DoseMe’s Genetic Biomarker Capabilities for Precision Dosing

DoseMe Adds Cefepime to Its Model-informed Precision Dosing Platform

Safeguarding the Kidneys: A Comprehensive Guide To Vancomycin Nephrotoxicity Prevention

Cracking the PK Code: The Art of Precision Beta-lactam Dosing

Webinar registration | Precision Beta-lactam Dosing | 10.25.23

DoseMe Selected as a Pharma 2023 Innovation Award Winner

From Theory to Practice: Maximizing Aminoglycoside Efficacy with AUC-guided TDM

Sarah Bush Lincoln Adopts DoseMe Precision Dosing Platform to Improve Overall Level of Patient Care

A.C. Camargo Cancer Center Harnesses the Power of DoseMe Precision Dosing Platform to Substantially Reduce Toxicity and Kidney Injuries

DoseMe Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance

Webinar registration | Maximizing Aminoglycoside Efficacy with AUC-guided TDM

New England Life Care Selects DoseMe to Support New Initiatives Around Compliance Protocols

DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer

Red Man Syndrome: A Close Look at Causes, Symptoms, and Treatment

Mastering Big Data for Therapeutic Drug Monitoring

Is Vancomycin an Aminoglycoside? Understanding Antibiotic Classification

Bayesian Dosing of Tobramycin Outperforms Other Personalized Dosing Strategies at Pediatric Hospital

Fairlong Capital LLC acquires DoseMeRx

5 Ways Big Data Will Transform Clinical Pharmacy

Preparing for the New and Revised Antibiotic Stewardship Requirements — Is Your Institution Ready?

Webinar registration | Mastering Big Data for Therapeutic Drug Monitoring | October 25 2022

Meta-analysis supports the cost-effectiveness of Bayesian dosing software—but reinforces perceived barriers to adoption

ID Connect | Vancomycin & MRSA Pneumonia | Joint Webinar | August 16th 2022, 1pm ET

Bayesian Software Costs For Vancomycin Dosing

DoseMeRx and Wolters Kluwer

Wolters Kluwer | Vancomycin Bayesian Dosing | Joint Webinar | June 15th 2022, 12pm CST

Southwest Leadership Forum | Virtual | March 3, 2022, 12pm CT/11am MT

Do’s and Don’ts of Bayesian Dosing

How to Create a Vancomycin AUC-based Protocol in 5 Steps

Implementing the 2020 Vancomycin Guidelines

Vancomycin From Trough to AUC

Vancomycin vs. Penicillin: How do they Differ Clinically?

Vancomycin AUC Calculation

Do’s and Dont’s of Bayesian Dosing: Webinar Recording

Bayesian dosing versus free first-order calculators – what’s the difference?

Do’s and Don’ts of Bayesian Dosing | Webinar | Sep. 22, 2021, 2pm ET

Vancomycin toolkit

SIDP releases vancomycin AUC dosing toolkit

2020 Vancomycin Guidelines with ASHP | Joint Webinar | May 18th 2021, 3pm ET

DoseMeRx and Wolters Kluwer

Wolters Kluwer Vancomycin AUC Dosing | Joint Webinar | May 4th 2021, 12pm CST

Infectious Disease Connect® Announces Precision Dosing Powered

One Year Later: Experience and Insights From One of The 2020 Vancomycin Guideline Authors

Tabula Rasa HealthCare Announces Clinical Advisory Board for its Hospital Division

ASHP Partners with Tabula Rasa HealthCare’s DoseMeRx™ to Offer Bayesian Dosing Solution for Vancomycin

In Case You Missed It: IDWeek Recap

TRHC’s DoseMeRx® Partners with Physiomics to Provide Precision Dosing for Oncology Medications

DoseMeRx and Wolters Kluwer

Wolters Kluwer Targets Precision Dosing with TRHC’s DoseMeRx Integration

ASHP Midyear: Presentations You Shouldn’t Miss This Year

Optimizing Vancomycin AUC Dosing in Vascular Surgery Patients at University Hospitals of Leicester NHS Trust

Neil Medical Group Selects TRHC’s DoseMeRx to Provide Precision Dosing Services For Long-term Care Facilities

DoseMeRx Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture and Meet Compliance Requirements

Vancomycin Mechanism of Action

Vancomycin Side Effects

New Study Finds DoseMeRx Increases Vancomycin AUC Target Attainment

Implementing the 2020 Vancomycin Guidelines: Webinar Recording

Intravenous Vancomycin

Vancomycin Renal Dose

Optimizing Therapy with Cyclosporine at the University Medical Centre Maribor

Take the Opportunity to Steward Vancomycin with Release of New Dosing Guidelines

Tabula Rasa HealthCare’s DoseMeRx Integrates with The Sanford Guide

Vancomycin Dosing Guidelines: What You Need to Know

Tabula Rasa HealthCare Announces VigiLanz Precision Dosing Powered by DoseMeRx

Vancomycin infusion guidelines

Looking for literature on vancomycin dosing targeting AUC/MIC?

DoseMe to Sponsor the 4th Annual Middle Tennessee Antimicrobial Stewardship Symposium

Preparing for the New Vancomycin Guidelines – What Should You Be Considering?

AUC24 Vancomycin Bayesian-based dosing: Increasing Therapeutic Target Attainment with Decreased Monitoring Costs

DoseMeRx Optimizes Vancomycin Dosing inside Epic EHR

ASHP Midyear – DoseMeRx to Showcase Cerner & Epic Integration

Vancomycin trough levels: Upcoming 2019 therapeutic drug monitoring recommendations

DoseMe® to Provide Precision Dosing Services for St. Joseph’s/Candler

IDWeek: Optimal Vancomycin Dosing using Bayesian Method Poster Presentations

BayCare Health System to Present on Improved Pharmacy Operations using DoseMeRx at CHC2019

DoseMe Bayesian Forecasting Method Receives Rating of Most User-Friendly in Clinical Study

BayCare Health System To Showcase DoseMeRx at CHC 2019

Dr Kristi Kuper Joins DoseMe as Director of Clinical Pharmacy

Bainbridge Health Partners with DoseMe To Expand Medication Management Capabilities to Health Systems

Vancomycin From Trough to AUC: RWJ Barnabas Health Experience | Recorded Webinar

Houston Methodist Selects DoseMe For System-wide Precision Dosing Technology

DoseMe Signs 3-Year Agreement with Portugal’s National Health Service

DoseMe Showcase at ASHP Summer Meeting 2019

Vancomycin Dosing Therapeutic Guideline 2019: What’s Changing?

Optimizing vancomycin dosing in Cerner’s PowerChart with DoseMeRx SMART-on-FHIR

Vancomycin dosing in complex and critically-ill patients

Vancomycin dosing and monitoring for adults receiving intermittent hemodialysis

Vancomycin dosing in obese and morbidly obese patients

New Vancomycin Obese, Hemodialysis and Complex Models Released

DoseMe Joins Tabula Rasa HealthCare

Vancomycin Dosing in Pediatrics

Tabula Rasa HealthCare to Acquire DoseMe

Texas Children’s & Houston Methodist Vizient Webinar

Therapeutic Drug Monitoring for Busulfan IV Dosing

DoseMeRx on Show at ASHP Midyear Clinical Meeting

Vancomycin dosing: to AUC or Not?

Making A Difference Through Optimizing Cyclosporine Treatment With DoseMe

A New Approach to Therapeutic Drug Monitoring of Tobramycin in Cystic Fibrosis

Vancomycin Loading Dose: The Pharmacokinetics to Consider

DoseMe to Present at IATDMCT Congress 2018

University Hospitals of Leicester NHS Trust Select DoseMeRx to Optimize ICU Vancomycin Dosing

Accurate Prediction of Vancomycin Levels to Optimize Care

Healix Announces Strategic Partnership with DoseMe for Precision Dosing

DoseMe Selected to Showcase at 2018 BIO International Convention

DoseMe Supports 27th Annual PPAG Meeting

DoseMeRx to Be Showcased at European Association of Hospital Pharmacists Congress

DoseMe Increases FHIR Power in Epic’s App Orchard

Precision dosing set to shake up medicine

Priscilla Rogers, formally IBM Research – Australia, joins DoseMe Advisor Board

DoseMe Joins Microsoft for Healthcare Digital Innovation HISA Breakfast Series

DoseMe and Cerner – Tomorrow, Today – Cerner Health Conference 2017

DoseMe Wins Place in Inaugural ANDHealth+ Program

DoseMe to Showcase Precision Dosing Decision Support at Cerner Health Conference

Improving vancomycin dosing by shifting to AUC

DoseMe teams up with EHR vendor Cerner to deliver Precision Medicine

Healthcare has come a long way, but there’s always room for improvement

DoseMe Bets Big on Precision Dosing in USA

Antibiotic Resistance and The Right Dose, Right Drug, Right Time

A Dose of Confidence with Microsoft ASD Certification

TDI Welcomes Leading Teaching Institutions to Ever Expanding Family

A New Approach to TDM of Tobramycin in CF

DoseMe Provides Dose of Advice to Queensland’s Top Innovators at QLD iAwards

DoseMeRx ASHP Summer Debut

DoseMe set to deliver precision dosing at eHealth QLD Expo

Cash injection right medicine for DoseMe push into hospitals

Personalized Dosing – It’s here, but how do we do it?

DoseMe Partners with Microsoft

Delivering Precision Dosing to Australian Cancer Patients

DoseMe completes Series A financing, eyes global expansion

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2024 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.